Tenaya Therapeutics, Inc. (TNYA) Analysis

Stock Overview

$0.7

+$0.06 (+0.00%)

Volume: 0

Sector: N/A

Industry: N/A

Price Chart

Technical Indicators

Moving Averages

50-Day MA: N/A

200-Day MA: N/A

Relative Strength Index (RSI)

RSI (14): N/A

Neutral

Support & Resistance

Support: $N/A

Resistance: $N/A

52-Week Range

High: $N/A

Low: $N/A

Fundamental Data

Market Cap

N/A

P/E Ratio

N/A

EPS

$N/A

Beta

N/A

Recent News

Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

globenewswire.com • March 24, 2025

SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the publications of positive preclinical data for TN-201, the company's gene therapy candidate for Myosin-Binding Protein C3 (MYBPC3)-associated hypertrophic cardiomyopathy (HCM), in Nature Communications.

Read Full Article

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology's Annual Scientific Session

globenewswire.com • March 19, 2025

Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201

Read Full Article

Historical Performance

1 Day

N/A

1 Week

N/A

1 Month

N/A

3 Months

N/A

YTD

N/A

Historical Data

Last updated: March 24, 2025

Back to Daily Report